Key facts
- This page summarizes Charles V Baltic III's Form 4 filing for MEI Pharma, Inc. (MEIP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Mar 2023, 16:16.
Charles V Baltic III - 28 Feb 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)
- Reporting relationship
- Director
- Issuer ticker
- MEIP
- Reported as of
- 28 Feb 2023
- Net transaction value
- +$18,338
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2023, 16:16:07 UTC
- Prior SEC filing
- 07 Jul 2022
- Next SEC filing
- 12 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian G. Drazba, as attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles V Baltic III filed Form 4 for MEI Pharma, Inc. (MEIP) on 01 Mar 2023.
Change
- Previous filing in this sequence was filed on 07 Jul 2022.
- Current net transaction value: +$18,338.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEIP
transaction
Common Stock
Purchase
- Transaction value
- $18,338
- Shares
- +81,500
- Change %
- +336%
- Price
- $0.2250*
- Shares after
- 105,750
- Date
- 28 Feb 2023
- Ownership
- Direct
MEIP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,350
- Date
- 28 Feb 2023
- Ownership
- By Spouse
* marks a reported price that did not pass the local price check.